Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01969539 · ClinicalTrials.gov registry record · Phase 4
Ventilator Adapters for Combivent Respimat
A Phase 4 study, sponsored by Boehringer Ingelheim.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT01969539 is a Phase 4 study that was terminated before completion, run by Boehringer Ingelheim. The registered enrollment target is 11 participants.
The verdict
NCT01969539, a Phase 4 study, was terminated before completion, sponsored by Boehringer Ingelheim.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The general aim of this 1-day, open label, non-randomised, trial is to characterize the performance of two adapter devices designed to permit use of the Respimat® inhaler with patients requiring mechanical ventilation.
Interventions
- DRUG Combivent Respimat via tee adapter
- DRUG Combivent Respimat via ventilator adapter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-10-14 |
| Est. Completion | 2014-11-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01969539
The ClinicalTrials.gov registry entry for NCT01969539 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Combivent Respimat via tee adapter is the first listed.
NCT01969539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01969539 about?
NCT01969539 is a clinical study titled "Ventilator Adapters for Combivent Respimat". The general aim of this 1-day, open label, non-randomised, trial is to characterize the performance of two adapter devices designed to permit use of the Respimat® inhaler with patients requiring mechanical ventilation.
What is the current status of trial NCT01969539?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2013-10-14. Estimated completion is 2014-11-21.
What interventions are being tested in trial NCT01969539?
The interventions under investigation include: Combivent Respimat via tee adapter (DRUG), Combivent Respimat via ventilator adapter (DRUG).
Who is sponsoring clinical trial NCT01969539?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.